The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

The United Kingdom will study whether the use of weight loss drugs could get people back to work. UK Health Minister Wes ...

The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

More than a quarter of us have learned all we know about weight-loss jabs through social media, so GP Dr Bryony Henderson has helped clear up the myths and misunderstandings ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

have gone from niche diabetes treatments to the most in-demand weight-loss treatments in the world. Both Wegovy and Mounjaro have now been approved for treating obesity on the NHS, and the ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

The FDA approved Mounjaro and Ozempic for use by patients with diabetes in 2022 and 2017, respectively, but has not yet done so specifically for weight loss. Wegovy and Zepbound were approved for ...